Well Health Tech (WHTCF) Stock News

WELL Health Technologies (WHTCF) reported record Q1-2025 revenue of $294.1M, up 32% YoY. The company achieved Adjusted EBITDA of $27.6M, a 36% increase YoY. Total patient visits reached 1.6M, up 23% YoY, with Canadian visits growing 29%. Canadian operations showed strong 13% organic growth. Revenue was impacted by a $6.5M delay in Circle Medical revenue recognition. The company's Canadian business, including WELLSTAR and CYBERWELL, grew Four wall Adjusted EBITDA by 29% YoY to $18.7M. Looking ahead, WELL expects to integrate HEALWELL AI in Q2 2025, contributing approximately $120M in 2025 revenue. The company plans to reinitiate its share buyback program and has 11 signed LOIs worth $65M in revenues in its M&A pipeline.

WELL Health Technologies (WHTCF) reported strong Q1 2025 operational results, achieving record 1.6 million patient visits, representing 24% YoY growth with 14% organic growth. The company's Canadian operations led growth with 933,493 patient visits, showing 30% YoY growth (12% organic). Total care interactions reached 2.59 million, up 34% YoY. Technology interactions increased by 53% to 856,659, while billed provider hours grew 53% to 132,146. However, the company noted a $6.5M revenue impact due to Circle Medical's deferred revenue recognition, with approximately $58.4M in deferred revenue on the balance sheet. WELL will release its complete Q1 2025 financial results on May 14, 2025.

WELLSTAR Technologies, a subsidiary of WELL Health Technologies (TSX:WELL, OTCQX:WHTCF), has launched Nexus AI, a Canadian-built artificial intelligence platform for healthcare providers. The platform features advanced ambient scribe capabilities and integrates with Canadian EMR systems to streamline clinical workflows and reduce administrative burden.

Developed by physicians and AI researchers from the University of Toronto and HEALWELL AI, Nexus AI is already being used by thousands of providers across 20 specialties in Canada. The platform will expand to include disease detection, medical coding, billing automation, and clinical decision support features. Notably, Nexus AI is participating in Canada Health Infoway's AI Scribe Program, which will fund one-year licenses for up to 10,000 eligible primary care clinicians.

WELL Health Technologies (TSX: WELL) has rebranded its cybersecurity division as 'CYBERWELL', consolidating four trusted cybersecurity businesses - Source44, SeekIntoo, Cycura, and Proack Security - into a unified data protection platform. The company has appointed Jeffrey Engle, a seasoned cybersecurity executive and U.S. special operations veteran, as CEO to lead the division. Under Engle's leadership, CYBERWELL will focus on driving growth through recurring revenue, disciplined acquisitions, and international expansion, particularly targeting healthcare and critical infrastructure sectors. The strategic consolidation aims to enhance operational efficiency, strengthen brand equity, and position WELL to better serve the growing demand for advanced cybersecurity capabilities across North America and beyond. WELL indicates that CYBERWELL may be considered for a future spinout, potentially creating additional shareholder value.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has scheduled the release of its Fourth Quarter and Year End 2024 financial results on April 14, 2025, after market close. The digital healthcare company will host a conference call and webcast to discuss the results on April 15, 2025, at 1:00 PM ET (10:00 AM PT).

The earnings call will be led by Chairman and CEO Hamed Shahbazi and CFO Eva Fong. Participants can join through various dial-in options, including local Toronto (437-900-0527), Vancouver (604-259-0841), North American toll-free (1-888-510-2154), and international lines.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has received a Management Cease Trade Order (MCTO) from the British Columbia Securities Commission following a delay in filing its Annual Filings for the year ended December 31, 2024. The MCTO restricts the CEO and CFO from trading company securities until the required documents are filed.

The Annual Filings include the company's annual information form, audited annual financial statements, and management's discussion and analysis. During this period, the company has committed not to issue or acquire securities from insiders or employees. The MCTO does not affect non-insider shareholders' ability to trade.

The company will provide bi-weekly default status reports and announce completion once the Annual Filings are submitted to SEDAR+.

WELL Health Technologies Corp. (WHTCF) has exercised its call option rights to acquire significant shares in HEALWELL AI Inc. The transaction occurred concurrent with HEALWELL's acquisition of Orion Health Holdings for approximately NZ$175 million on April 1, 2025.

Through the exercise of the Call Right, WELL acquired 30.8 million Subordinate Voting Shares and 30.8 million Multiple Voting Shares from HEALWELL's founding shareholders. Following the transaction, WELL now owns 97,473,161 HEALWELL Shares and 30,800,000 Multiple Voting Shares, representing approximately 37% of the economic interest and 69% of the voting rights in HEALWELL on a partially-diluted basis.

WELL Health Technologies Corp. (WHTCF) has announced its intention to exercise a call option to acquire shares in HEALWELL AI Inc. concurrent with HEALWELL's acquisition of Orion Health Holdings The call option allows WELL to purchase up to 30.8 million Subordinate Voting Shares and 30.8 million Multiple Voting Shares from HEALWELL's founding shareholders at $0.125 and $0.0001 per share respectively.

HEALWELL is set to acquire Orion Health for approximately NZ$175 million, with closing anticipated on April 1, 2025. Following the exercise of the call right and the Orion Health acquisition, WELL is expected to own approximately 37% of the economic interest and 69% of the voting rights in HEALWELL on a partially-diluted basis. WELL was previously approved as a control person of HEALWELL by shareholders and the Toronto Stock Exchange.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has reported record patient visits for fiscal year 2024, achieving 5.7 million total patient visits, representing a significant 32% year-over-year growth, with organic growth accounting for 30%.

The company's Canadian patient services business demonstrated exceptional performance, recording 3.125 million patient visits, marking a 35% year-over-year increase. The organic growth in Canadian operations was particularly strong at 32%, comprised of 26% same clinic sales growth and 6% absorption growth.

These preliminary operational results highlight WELL's success in leveraging its technology-enabled care model to drive strong organic growth across its enterprise, particularly in its Canadian Clinics division.